Evidence map›Paper›PMID 38932264›Full record

ReviewViruses2024

Making a Monkey out of Human Immunodeficiency Virus/Simian Immunodeficiency Virus Pathogenesis: Immune Cell Depletion Experiments as a Tool to Understand the Immune Correlates of Protection and Pathogenicity in HIV Infection.

Jen Symmonds, Thaidra Gaufin, Cuiling Xu, Kevin D Raehtz, Ruy M Ribeiro, Ivona Pandrea, Cristian Apetrei

Abstract readReview
In one paragraph

Review in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jen SymmondsDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0002-2030-7005
Thaidra GaufinTulane National Primate Research Center, Tulane University, Covington, LA 70433, USA.
Cuiling XuDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Kevin D RaehtzDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0002-0687-7714
Ruy M RibeiroTheoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.ORCID 0000-0002-3988-8241
Ivona PandreaDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Cristian ApetreiDepartment of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0002-0322-7185

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
SIV Pathogenesis in African Green Monkeys and Pigtailed MacaquesR01HL117715 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VASILE PANDREA, IVONA · 2012 to 2021
$7.0M
Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPsR01HL123096 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VASILE PANDREA, IVONA · 2015 to 2025
$6.8M
Resource CoreP40OD028116 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2020 to 2026
$5.9M
Assessing the Role of GI Tract Dysfunction to HIV/SIV Disease ProgressionR01DK113919 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CRISTIAN APETREI, Ivona Vasile-Pandrea · 2017 to 2026
$5.7M
New Strategy to Improve Gastrointestinal Health in SIV/HIVR01DK119936 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APETREI, CRISTIAN · 2018 to 2022
$5.1M
Impact of metabolic programing of T cells from the GI tract and related tissues on HIV reservoir seeding, maintenance and reactivationR01DK131476 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CRISTIAN APETREI · 2021 to 2026
$3.9M
Animal Model for Testing SIV Latency Reversal StrategiesR01AI119346 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APETREI, CRISTIAN · 2015 to 2019
$3.4M
Probing the role of adenosine pathway in SIV pathogenesisR01AI179317 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ivona Vasile-Pandrea · 2023 to 2026
$3.3M
Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted ImmunotherapyR01HL154862 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FEINSTEIN, MATTHEW JOEL, VASILE PANDREA, IVONA · 2020 to 2023
$3.1M
Quantifying Immune VS. Viral Killing of SIV Infected and Latently Infected CellsR01AI104373 · NIAID · LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB · PI RIBEIRO, RUY M · 2013 to 2016
$2.7M
International Heart and Lung Institute R01 HL117715 (IP), R01 HL123096 (IP), and R01 HL154862 (IP)National Institute of Allergy and Infectious Diseases R01 AI119346 (CA)NHLBI NIH HHS R01 HL117715NHLBI NIH HHS R01 HL123096NHLBI NIH HHS R01 HL154862NIAID NIH HHS R01 AI104373NIAID NIH HHS R01 AI119346NIAID NIH HHS R01 AI179317NIAID NIH HHS U24 AI126683NIDDK NIH HHS DK119936 (CA), R01 DK113919 (IP/CA), R01 DK131476 (CA), and R01 DK130481 (IP)NIDDK NIH HHS R01 DK113919NIDDK NIH HHS R01 DK119936NIDDK NIH HHS R01 DK130481NIDDK NIH HHS R01 DK131476NIH HHS P40 OD028116NIH HHS P51 OD011104
6 · The paper itself

Abstract

Understanding the underlying mechanisms of HIV pathogenesis is critical for designing successful HIV vaccines and cure strategies. However, achieving this goal is complicated by the virus's direct interactions with immune cells, the induction of persistent reservoirs in the immune system cells, and multiple strategies developed by the virus for immune evasion. Meanwhile, HIV and SIV infections induce a pandysfunction of the immune cell populations, making it difficult to untangle the various concurrent mechanisms of HIV pathogenesis. Over the years, one of the most successful approaches for dissecting the immune correlates of protection in HIV/SIV infection has been the in vivo depletion of various immune cell populations and assessment of the impact of these depletions on the outcome of infection in non-human primate models. Here, we present a detailed analysis of the strategies and results of manipulating SIV pathogenesis through in vivo depletions of key immune cells populations. Although each of these methods has its limitations, they have all contributed to our understanding of key pathogenic pathways in HIV/SIV infection.

Indexed as

HIV InfectionsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAnimalsDisease Models, AnimalHaplorhiniHIVHumansLymphocyte DepletionAIDSB-lymphocyteshuman immunodeficiency virusnatural killer cellsnon-human primatesregulatory T-cellssimian immunodeficiency virusT-lymphocytes

Identifiers

PMID38932264
PMCPMC11209256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.